AI-generated summary
The authors studied diurnal Arvicanthis niloticus rodents kept in constant darkness and exposed to light in early subjective day, measuring Fos as a marker of neural activity. Light increased Fos in orexin neurons and the dorsal raphe nucleus but not the suprachiasmatic nucleus, and blocking orexin receptor type 1 reduced the raphe response. The authors suggest an orexinergic pathway may link light to mood-regulating areas, though this is an animal study.
- Who or what was studied
- Diurnal Arvicanthis niloticus rodents kept in constant darkness
- Limits stated in the abstract
- The study is in rodents using Fos as a marker of neural activity, and the abstract does not report the number of animals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.